ES2575697T3 - Métodos y sondas para detectar cáncer de esófago - Google Patents

Métodos y sondas para detectar cáncer de esófago Download PDF

Info

Publication number
ES2575697T3
ES2575697T3 ES12178901.0T ES12178901T ES2575697T3 ES 2575697 T3 ES2575697 T3 ES 2575697T3 ES 12178901 T ES12178901 T ES 12178901T ES 2575697 T3 ES2575697 T3 ES 2575697T3
Authority
ES
Spain
Prior art keywords
probes
locus
precursor lesion
esophageal carcinoma
specific probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12178901.0T
Other languages
English (en)
Inventor
Kevin Halling
Larry E Morrison
Shannon Brankley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Abbott Molecular Inc
Mayo Clinic in Florida
Original Assignee
Mayo Foundation for Medical Education and Research
Abbott Molecular Inc
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research, Abbott Molecular Inc, Mayo Clinic in Florida filed Critical Mayo Foundation for Medical Education and Research
Application granted granted Critical
Publication of ES2575697T3 publication Critical patent/ES2575697T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Un método para la detección de un carcinoma de esófago o una lesión precursora en un sujeto, en donde el carcinoma o la lesión precursora detectado selectivamente se selecciona del grupo que consiste en displasia de alto grado (DAG) y adenocarcinoma de esófago (AE), comprendiendo el método: a) poner en contacto una muestra biológica que comprende células del esófago procedentes del sujeto del que se sospecha que tiene un carcinoma de esófago con un conjunto de sondas cromosómicas para detectar selectivamente un carcinoma de esófago o una lesión precursora en la muestra, si la hubiera, en condiciones para hibridar específicamente las sondas a sus ácidos nucleicos diana presentes en la muestra; en donde dicho conjunto consiste en una sonda específica del locus 20q13, una sonda de recuento cromosómico del cromosoma 9, una sonda específica del locus 7p12, una sonda específica del locus 5q21-22; y b) detectar un patrón de hibridación para el conjunto de sondas cromosómicas con la muestra biológica, en donde el patrón de hibridación es indicativo de la presencia o ausencia de un carcinoma de esófago o de una lesión precursora.

Description

16
20
21
30
32
ES12178901.0T 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago Active ES2575697T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65474205P 2005-02-18 2005-02-18
US654742P 2005-02-18

Publications (1)

Publication Number Publication Date
ES2575697T3 true ES2575697T3 (es) 2016-06-30

Family

ID=36917111

Family Applications (3)

Application Number Title Priority Date Filing Date
ES06735413.4T Active ES2528382T3 (es) 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago
ES12178901.0T Active ES2575697T3 (es) 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago
ES14176615.4T Active ES2644641T3 (es) 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES06735413.4T Active ES2528382T3 (es) 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES14176615.4T Active ES2644641T3 (es) 2005-02-18 2006-02-17 Métodos y sondas para detectar cáncer de esófago

Country Status (6)

Country Link
US (2) US8034577B2 (es)
EP (4) EP1853729B1 (es)
JP (4) JP2008537097A (es)
CA (1) CA2598006C (es)
ES (3) ES2528382T3 (es)
WO (1) WO2006089163A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1929044B1 (en) * 2005-09-02 2017-08-09 The Regents of The University of California Methods and probe combinations for detecting melanoma
EP1941050B1 (en) 2005-09-20 2017-04-26 Janssen Diagnostics, LLC Methods and composition to generate unique sequence dna probes, iabeling of dna probes and the use of these probes
US20080133141A1 (en) * 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2949753A1 (en) 2005-12-22 2007-07-05 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US7960110B2 (en) * 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
US8679759B2 (en) * 2007-08-01 2014-03-25 The Johns Hopkins University Esophageal cancer markers
DK2713890T3 (en) 2011-05-26 2018-04-16 Adn Int Llc Expandable device for removing tissue from an aerodigestive body cavity
EP3272882B1 (en) * 2011-09-23 2019-02-20 Academisch Medisch Centrum Materials and methods for prognosis of progression of barrett's esophagus
US10255410B2 (en) * 2011-12-01 2019-04-09 Interpace Diagnostics Corporation Methods for treating Barrett's metaplasia and esophageal adenocarcinoma
US10131942B2 (en) 2011-12-01 2018-11-20 Interpace Diagnostics Corporation Methods for treating barrett's metaplasia and esophageal adenocarcinoma
WO2013170215A1 (en) * 2012-05-11 2013-11-14 Fred Hutchinson Cancer Research Center Methods for predicting and detecting cancer risk
US20150126395A1 (en) * 2013-11-07 2015-05-07 Cellay, Inc. Methods and Kits for Detecting a Prostate Carcinoma and Predicting Disease Outcomes for Prostate Cancers
DK3109324T5 (en) * 2015-06-23 2019-02-11 Zytovision Gmbh PROCEDURE FOR THE DETECTION OF CHROMOSOMA DIFFERENCES
JP2022535747A (ja) * 2019-05-28 2022-08-10 ケース ウエスタン リザーブ ユニバーシティ Ｄｎａのメチル化を保存するための組成物および方法
AU2021281223A1 (en) 2020-05-27 2023-01-05 Case Western Reserve University Compositions and methods for preserving DNA methylation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US617468A (en) 1899-01-10 miller
US5756696A (en) 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US5491224A (en) * 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
CA2750033A1 (en) 2001-02-20 2002-08-29 Vysis, Inc. Methods and probes for the detection of cancer

Also Published As

Publication number Publication date
EP1853729A4 (en) 2010-05-05
US20060211019A1 (en) 2006-09-21
JP2017205119A (ja) 2017-11-24
EP3246417B1 (en) 2019-09-11
EP2789697B1 (en) 2017-07-19
US20120141991A1 (en) 2012-06-07
EP2540842B1 (en) 2016-04-06
JP2019213542A (ja) 2019-12-19
EP1853729B1 (en) 2014-12-03
CA2598006C (en) 2018-12-11
JP2015165807A (ja) 2015-09-24
EP2540842A2 (en) 2013-01-02
JP2008537097A (ja) 2008-09-11
WO2006089163A2 (en) 2006-08-24
EP1853729A2 (en) 2007-11-14
ES2644641T3 (es) 2017-11-29
JP6371252B2 (ja) 2018-08-08
EP2789697A2 (en) 2014-10-15
EP2540842A3 (en) 2013-04-03
EP2540842B8 (en) 2016-06-01
WO2006089163A3 (en) 2009-06-04
ES2528382T3 (es) 2015-02-09
EP2789697A3 (en) 2015-01-21
US8034577B2 (en) 2011-10-11
JP6662813B2 (ja) 2020-03-11
EP3246417A1 (en) 2017-11-22
CA2598006A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
ES2575697T3 (es) Métodos y sondas para detectar cáncer de esófago
Hong et al. MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens
ES2638640T3 (es) Ensayo de HPV RNAscope® para determinar el estado del HPV en los cánceres de cabeza y cuello y en lesiones cervicales
ES2578370T3 (es) Métodos para detectar fusiones génicas
CY1118000T1 (el) Διαδικασια υψηλης παροχης για αναλυση μεθυλιωσης dna
US10106854B2 (en) Biomarkers for prostate cancer
Freier et al. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland
ES2767853T3 (es) Detección de la restricción de cadena ligera de inmunoglobulina por hibridación in situ de ARN
ES2721539T3 (es) Materiales y métodos para pronóstico de evolución de esófago de Barrett
WO2016168174A1 (en) Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies
DK1631686T3 (da) Påvisning af dysplasi i høj grad i cervicale celler
Gao et al. Label-free fluorescence detection of DNA methylation and methyltransferase activity based on restriction endonuclease Hpa II and exonuclease III
CY1114785T1 (el) Ανιχνευση και καταμετρηση μικροοργανισμων
Yin et al. Rapid detection of methyltransferases utilizing dumbbell DNA-templated copper nanoparticles
ES2565053T3 (es) Métodos y ácidos nucleicos para el análisis de metilación de CpG asociada con el desarrollo de trastornos proliferativos de células de próstata
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
JP5258760B2 (ja) メチル化核酸又は非メチル化核酸を増幅する方法
DE60136277D1 (de) Verfahren zum nachweis von krebs
JPWO2019178496A5 (es)
DE602004030910D1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
ATE478158T1 (de) Hybridisierungsverfahren
US20140235455A1 (en) Use of hoxa9 gene as a biomarker for the detection of hepatocellular carcinoma
Michaelson-Cohen et al. Genome-wide de novo methylation in epithelial ovarian cancer
ES2720864T3 (es) Materiales y métodos para el diagnóstico y pronóstico de cáncer pancreatobiliar
CN110229913A (zh) 基于甲基化水平检测肿瘤的广谱性标记物及其应用